Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Theranostics|June 16, 2025
Loss of <i>SLC25A20</i> in Pancreatic Adenocarcinoma Reversed the Tumor-Promoting Effects of a High-Fat DietSang Myung Woo, Ho Lee, Joon Hee Kang, et al.The Journal of Cell Biology|October 26, 2011
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transitionNam Hee Kim, Hyun Sil Kim, Xiao-Yan Li, et al.Cancer Cell International|October 11, 2022
Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheresJin-Kyoung Shim, Seonah Choi, Seon-Jin Yoon, et al.British Journal of Cancer|October 13, 2017
ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancerIkhyun Jun, Hyung Soon Park, He Piao, et al.Science Signaling|November 3, 2011
p53 and microRNA-34 are suppressors of canonical Wnt signalingNam Hee Kim, Hyun Sil Kim, Nam-Gyun Kim, et al.Biomaterials|September 15, 2014
A platform technique for growth factor delivery with novel mode of actionNam Hee Kim, Yong Hoon Cha, Hyun Sil Kim, et al.Oncotarget|September 2, 2016
Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A)Junjeong Choi, Ji-Hyun Lee, Ilkyoo Koh, et al.Journal of Neuro-Oncology|November 17, 2022
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheresSeo Jin Kim, Soo Jeong Park, Junseong Park, et al.Oncotarget|April 19, 2017
Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interactionSung Yong Ahn, Nam Hee Kim, Kyungro Lee, et al.Genome Research|January 13, 2018
Targeting mutant <i>KRAS</i> with CRISPR-Cas9 controls tumor growthWonjoo Kim, Sangeun Lee, Han Sang Kim, et al.Pageof 9